Correction to: Randomized trial of an increased dose of calcium channel blocker or angiotensin II type 1 receptor blocker as an add-on intensive depressor therapy in type 2 diabetes mellitus patients with uncontrolled essential hypertension: the ACADEMIE Study

Heart Vessels. 2020 Apr;35(4):603-604. doi: 10.1007/s00380-019-01374-5.

¹ Department of Cardiology, Fukuoka University School of Medicine, Fukuoka, Japan.
² Clinical Research and Ethics Center, Fukuoka University School of Medicine, Fukuoka, Japan.
³ Department of Laboratory Medicine, Fukuoka University School of Medicine, Fukuoka, Japan.
⁴ Shirotani Hospital, Fukuoka, Japan.
⁵ Murakami Karindoh Hospital, Fukuoka, Japan.
⁶ Fukuoka University Medical Education Center, Fukuoka University School of Medicine, Fukuoka, Japan.
⁷ Showa Hospital, Fukuoka, Japan.
⁸ Tanigawa Hospital, Nagasaki, Japan.
⁹ Futata Tetsuhiro Clinic, Fukuoka, Japan.
¹⁰ Fukushima Hospital, Oita, Japan.
¹¹ Fukuseikai Hospital, Fukuoka, Japan.
¹² Izumi General Medical Center, Kagoshima, Japan.
¹³ Department of Molecular Cardiovascular Therapeutics, Fukuoka University School of Medicine, Fukuoka, Japan.
¹⁴ Department of Cardiology, Fukuoka University School of Medicine, Fukuoka, Japan. miuras@cis.fukuoka-u.ac.jp.
¹⁵ Department of Molecular Cardiovascular Therapeutics, Fukuoka University School of Medicine, Fukuoka, Japan. miuras@cis.fukuoka-u.ac.jp.

Abstract

In the Original publication of the article, the legend appearing inside the flow chart has been incorrectly published.